Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $311M | 0.15% |
4,686,000
+740,900
| +19% | +$45.8M |
|
102
PUT
Costco
COST
$420B
| $306M | 0.15% |
2,007,900
+775,900
| +63% | +$125M |
|
103
CALL
Boeing
BA
$169B
| $305M | 0.15% |
2,318,100
+206,000
| +10% | +$27.1M |
|
|
TWTR
104
DELISTED
Twitter, Inc.
TWTR
| $305M | 0.15% |
13,228,504
+1,610,464
| +14% | +$30.3M |
|
105
VanEck Gold Miners ETF
GDX
$31.8B
| $304M | 0.15% |
11,483,635
+6,089,291
| +113% | +$175M |
|
|
106
PUT
VanEck Gold Miners ETF
GDX
$31.8B
| $303M | 0.15% |
11,363,200
+694,500
| +7% | +$19.9M |
|
107
PUT
Baidu
BIDU
$31.6B
| $303M | 0.15% |
1,662,800
-109,800
| -6% | -$19M |
|
108
PUT
FedEx
FDX
$76.9B
| $292M | 0.14% |
1,670,800
+68,500
| +4% | +$11.2M |
|
|
CELG
109
CALL
DELISTED
Celgene Corp
CELG
| $291M | 0.14% |
2,784,900
-1,290,600
| -32% | -$140M |
|
110
CALL
Merck
MRK
$376B
| $291M | 0.14% |
4,879,488
+1,356,217
| +38% | +$79.3M |
|
111
CALL
Caterpillar
CAT
$381B
| $288M | 0.14% |
3,243,400
-373,800
| -10% | -$30.6M |
|
|
112
Meta Platforms (Facebook)
META
$1.4T
| $282M | 0.14% |
2,197,284
+2,142,019
| +3,876% | +$266M |
|
113
PUT
Berkshire Hathaway Class B
BRK.B
$1.06T
| $282M | 0.14% |
1,950,300
-186,400
| -9% | -$27.3M |
|
|
114
CALL
VanEck Gold Miners ETF
GDX
$31.8B
| $279M | 0.13% |
10,470,200
-564,200
| -5% | -$16.2M |
|
115
CALL
iShares Biotechnology ETF
IBB
$10.7B
| $279M | 0.13% |
2,892,600
+216,900
| +8% | +$20.6M |
|
116
CALL
Broadcom
AVGO
$1.75T
| $269M | 0.13% |
15,574,000
-1,581,000
| -9% | -$26.4M |
|
117
PUT
iShares US Real Estate ETF
IYR
$4.62B
| $266M | 0.13% |
3,297,100
-3,441,600
| -51% | -$285M |
|
118
CALL
Pfizer
PFE
$160B
| $266M | 0.13% |
8,263,360
+94,438
| +1% | +$3.16M |
|
119
CALL
Wells Fargo
WFC
$254B
| $263M | 0.13% |
5,949,400
-401,000
| -6% | -$19.2M |
|
|
TWTR
120
CALL
DELISTED
Twitter, Inc.
TWTR
| $262M | 0.13% |
11,377,300
+7,093,200
| +166% | +$133M |
|
121
CALL
Humana
HUM
$45.5B
| $262M | 0.13% |
1,480,900
+332,000
| +29% | +$57.6M |
|
122
CALL
AutoZone
AZO
$48.3B
| $261M | 0.13% |
340,300
+177,400
| +109% | +$138M |
|
123
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.4B
| $261M | 0.13% |
6,523,800
+1,964,800
| +43% | +$79.2M |
|
124
CALL
Charter Communications
CHTR
$17.9B
| $258M | 0.12% |
956,500
+370,700
| +63% | +$93.6M |
|
125
CALL
Qualcomm
QCOM
$169B
| $258M | 0.12% |
3,764,500
+139,200
| +4% | +$8.47M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.